Cancer Profiling Market By Technology, Technique and Application - Global Industry Analysis & Forecast to 2027
Published On : March 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC032820
Cancer Profiling Market By Technology (Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), Microarray, Quantitative Polymerase Chain Reaction (QPCR), In Situ Hybridization (ISH), Chromogenic In Situ Hybridization (CISH)) Technique (Proteomics, Metabolomics, Genomics, Epigenetics) Application (Personalized Medicine, Prognostics, Diagnostics, Biomarker Discovery, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cancer Profiling Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Cancer profiling helps with individualizing disease treatment by giving valuable data at the molecular or genetic dimension. This encourages medicinal specialists to plan a fitting treatment for patients who have cancer. This procedure helps with considering a people disease cells and in dissecting the hereditary qualities and unique biomarkers.
Drivers and Restraints
The worldwide market is driven by developing interest for cancer profiling strategy by oncologists to analyze or regard diseases just as foresee reaction to focused treatment. Furthermore, ascend in appropriation of cancer biomarkers for tumor profiling, increment in frequency of disease over the globe, and development being used of cutting edge sequencing procedure for disease profiling help the market development. Nonetheless, high fiscal speculations for the advancement of biomarkers and lack of talented experts or oncologists explicit to tumor profiling hamper the market development.
Regional Insights
China offers worthwhile open doors for the market development, inferable from noteworthy improvement of accuracy medication in the locale.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Qiagen N.V.
- HTG Molecular Diagnostics, Inc
- Caris Life Sciences
- NanostringTechologies
- Ribomed Biotechnologies, Inc.
- Illumina, Inc.
- Neogenomics Laboratories Inc.,
- Genomic Health Inc
- Helomics Corporation
- Oxford Gene Technology
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cancer Profiling Market, By Technology, Estimates and Forecast, 2017-2027($Billion)
o Next-Generation Sequencing (NGS)
o Immunohistochemistry (IHC)
o Fluorescence In Situ Hybridization (FISH)
o Microarray
o Quantitative Polymerase Chain Reaction (QPCR)
o In Situ Hybridization (ISH)
o Chromogenic In Situ Hybridization (CISH)
· Cancer Profiling Market, By Technique, Estimates and Forecast, 2017-2027($Billion)
o Proteomics
o Metabolomics
o Genomics
o Epigenetics
· Cancer Profiling Market, By Application, Estimates and Forecast, 2017-2027($Billion)
o Personalized Medicine
o Prognostics
o Diagnostics
o Biomarker Discovery
o Others
· Cancer Profiling Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Cancer Profiling Market, By Country
o U.S. Cancer Profiling Market
o Canada Cancer Profiling Market
o Mexico Cancer Profiling Market
o Europe
§ Europe Cancer Profiling Market, By Country
o Germany Cancer Profiling Market
o UK Cancer Profiling Market
o France Cancer Profiling Market
o Russia Cancer Profiling Market
o Italy Cancer Profiling Market
o Rest of Europe Cancer Profiling Market
o Asia-Pacific
§ Asia-Pacific Cancer Profiling Market, By Country
o China Cancer Profiling Market
o Japan Cancer Profiling Market
o South Korea Cancer Profiling Market
o India Cancer Profiling Market
o Southeast Asia Cancer Profiling Market
o Rest of Asia-Pacific Cancer Profiling Market
o South America
§ South America Cancer Profiling Market
o Brazil Cancer Profiling Market
o Argentina Cancer Profiling Market
o Columbia Cancer Profiling Market
o Rest of South America Cancer Profiling Market
o Middle East and Africa
§ Middle East and Africa Cancer Profiling Market
o Saudi Arabia Cancer Profiling Market
o UAE Cancer Profiling Market
o Egypt Cancer Profiling Market
o Nigeria Cancer Profiling Market
o South Africa Cancer Profiling Market
o Rest of MEA Cancer Profiling Market
Cancer Profiling Market, By Key Players
· Qiagen N.V.
· HTG Molecular Diagnostics, Inc
· Caris Life Sciences
· NanostringTechologies
· Ribomed Biotechnologies, Inc.
· Illumina, Inc.
· Neogenomics Laboratories Inc.
· Genomic Health Inc
· Helomics Corporation
· Oxford Gene Technology
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Profiling Market, By Technology
5.1. Introduction
5.2. Global Cancer Profiling Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Cancer Profiling Revenue and Revenue Share by Technology (2017-2027)
5.3. Next-Generation Sequencing (NGS)
5.3.1. Global Next-Generation Sequencing (NGS) Revenue and Growth Rate (2017-2027)
5.4. Immunohistochemistry (IHC)
5.4.1. Global Immunohistochemistry (IHC) Revenue and Growth Rate (2017-2027)
5.5. Fluorescence In Situ Hybridization (FISH)
5.5.1. Global Fluorescence In Situ Hybridization (FISH) Revenue and Growth Rate (2017-2027)
5.6. Microarray
5.6.1. Global Microarray Revenue and Growth Rate (2017-2027)
5.7. Quantitative Polymerase Chain Reaction (QPCR)
5.7.1. Global Quantitative Polymerase Chain Reaction (QPCR) Revenue and Growth Rate (2017-2027)
5.8. In Situ Hybridization (ISH)
5.8.1. Global In Situ Hybridization (ISH) Revenue and Growth Rate (2017-2027)
5.9. Chromogenic In Situ Hybridization (CISH)
5.9.1. Global Chromogenic In Situ Hybridization (CISH) Revenue and Growth Rate (2017-2027)
6. Cancer Profiling Market, By Technique
6.1. Introduction
6.2. Global Cancer Profiling Revenue and Market Share by Technique (2017-2027)
6.2.1. Global Cancer Profiling Revenue and Revenue Share by Technique (2017-2027)
6.3. Proteomics
6.3.1. Global Proteomics Revenue and Growth Rate (2017-2027)
6.4. Metabolomics
6.4.1. Global Metabolomics Revenue and Growth Rate (2017-2027)
6.5. Genomics
6.5.1. Global Genomics Revenue and Growth Rate (2017-2027)
6.6. Epigenetics
6.6.1. Global Epigenetics Revenue and Growth Rate (2017-2027)
7. Cancer Profiling Market, By Application
7.1. Introduction
7.2. Global Cancer Profiling Revenue and Market Share by Application (2017-2027)
7.2.1. Global Cancer Profiling Revenue and Revenue Share by Application (2017-2027)
7.3. Personalized Medicine
7.3.1. Global Personalized Medicine Revenue and Growth Rate (2017-2027)
7.4. Prognostics
7.4.1. Global Prognostics Revenue and Growth Rate (2017-2027)
7.5. Diagnostics
7.5.1. Global Diagnostics Revenue and Growth Rate (2017-2027)
7.6. Biomarker Discovery
7.6.1. Global Biomarker Discovery Revenue and Growth Rate (2017-2027)
7.7. Others
7.7.1. Global Others Revenue and Growth Rate (2017-2027)
8. Cancer Profiling Market, By Region
8.1. Introduction
8.2. Global Cancer Profiling Revenue and Market Share by Regions
8.2.1. Global Cancer Profiling Revenue by Regions (2017-2027)
8.3. North America Cancer Profiling by Countries
8.3.1. North America Cancer Profiling Revenue and Growth Rate (2017-2027)
8.3.2. North America Cancer Profiling Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Cancer Profiling by Countries
8.4.1. Europe Cancer Profiling Revenue and Growth Rate (2017-2027)
8.4.2. Europe Cancer Profiling Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Cancer Profiling by Countries
8.5.1. Asia-Pacific Cancer Profiling Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Cancer Profiling Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Cancer Profiling by Countries
8.6.1. South America Cancer Profiling Revenue and Growth Rate (2017-2027)
8.6.2. South America Cancer Profiling Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Cancer Profiling by Countries
8.7.1. Middle East and Africa Cancer Profiling Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Cancer Profiling Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Qiagen N.V.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. HTG Molecular Diagnostics, Inc
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Caris Life Sciences
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. NanostringTechologies
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Ribomed Biotechnologies, Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Illumina, Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Neogenomics Laboratories Inc.,
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Genomic Health Inc
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Helomics Corporation
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Oxford Gene Technology
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Cancer Profiling Market Competition, by Manufacturer
10.1. Global Cancer Profiling Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Cancer Profiling Price By Region (2017-2017)
10.3. Top 5 Cancer Profiling Manufacturer Market Share
10.4. Market Competition Trend
11. Cancer Profiling Market Forecast (2017-2027)
11.1. Global Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Cancer Profiling Market Forecast by Regions (2017-2027)
11.2.1. North America Cancer Profiling Market Forecast (2017-2027)
11.2.1.1. United States Cancer Profiling Market Forecast (2017-2027)
11.2.1.2. Canada Cancer Profiling Market Forecast (2017-2027)
11.2.1.3. Mexico Cancer Profiling Market Forecast (2017-2027)
11.2.2. Europe Cancer Profiling Market Forecast (2017-2027)
11.2.2.1. Germany Cancer Profiling Market Forecast (2017-2027)
11.2.2.2. France Cancer Profiling Market Forecast (2017-2027)
11.2.2.3. UK Cancer Profiling Market Forecast (2017-2027)
11.2.2.4. Russia Cancer Profiling Market Forecast (2017-2027)
11.2.2.5. Italy Cancer Profiling Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Cancer Profiling Market Forecast (2017-2027)
11.2.3. Asia-Pacific Cancer Profiling Market Forecast (2017-2027)
11.2.3.1. China Cancer Profiling Market Forecast (2017-2027)
11.2.3.2. Japan Cancer Profiling Market Forecast (2017-2027)
11.2.3.3. Korea Cancer Profiling Market Forecast (2017-2027)
11.2.3.4. India Cancer Profiling Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Cancer Profiling Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Cancer Profiling Market Forecast (2017-2027)
11.2.4. South America Cancer Profiling Market Forecast (2017-2027)
11.2.4.1. Brazil Cancer Profiling Market Forecast (2017-2027)
11.2.4.2. Argentina Cancer Profiling Market Forecast (2017-2027)
11.2.4.3. Columbia Cancer Profiling Market Forecast (2017-2027)
11.2.4.4. Rest of South America Cancer Profiling Market Forecast (2017-2027)
11.2.5. Middle East and Africa Cancer Profiling Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Cancer Profiling Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Cancer Profiling Market Forecast (2017-2027)
11.2.5.3. Egypt Cancer Profiling Market Forecast (2017-2027)
11.2.5.4. Nigeria Cancer Profiling Market Forecast (2017-2027)
11.2.5.5. South Africa Cancer Profiling Market Forecast (2017-2027)
11.2.5.6. Turkey Cancer Profiling Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Cancer Profiling Market Forecast (2017-2027)
11.3. Cancer Profiling Market Forecast by Technology (2017-2027)
11.3.1. Cancer Profiling Forecast by Technology (2017-2027)
11.3.2. Cancer Profiling Market Share Forecast by Technology (2017-2027)
11.4. Cancer Profiling Market Forecast by Technique (2017-2027)
11.4.1. Cancer Profiling Forecast by Technique (2017-2027)
11.4.2. Cancer Profiling Market Share Forecast by Technique (2017-2027)
11.5. Cancer Profiling Market Forecast by Application (2017-2027)
11.5.1. Cancer Profiling Forecast by Application (2017-2027)
11.5.2. Cancer Profiling Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Cancer Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Cancer Profiling Revenue and Revenue Share by Technology (2017-2018)
Figure Global Next-Generation Sequencing (NGS) Revenue and Growth Rate (2017-2018)
Figure Global Immunohistochemistry (IHC) Revenue and Growth Rate (2017-2018)
Figure Global Fluorescence In Situ Hybridization (FISH) Revenue and Growth Rate (2017-2018)
Figure Global Microarray Revenue and Growth Rate (2017-2018)
Figure Global Quantitative Polymerase Chain Reaction (QPCR) Revenue and Growth Rate (2017-2018)
Figure Global In Situ Hybridization (ISH) Revenue and Growth Rate (2017-2018)
Figure Global Chromogenic In Situ Hybridization (CISH) Revenue and Growth Rate (2017-2018)
Table Global Cancer Profiling Revenue and Revenue Share by Technique (2017-2018)
Figure Global Proteomics Revenue and Growth Rate (2017-2018)
Figure Global Metabolomics Revenue and Growth Rate (2017-2018)
Figure Global Genomics Revenue and Growth Rate (2017-2018)
Figure Global Epigenetics Revenue and Growth Rate (2017-2018)
Table Global Cancer Profiling Revenue and Revenue Share by Application (2017-2018)
Figure Global Personalized Medicine Revenue and Growth Rate (2017-2018)
Figure Global Prognostics Revenue and Growth Rate (2017-2018)
Figure Global Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Biomarker Discovery Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Cancer Profiling Revenue by Regions (2017-2018)
Figure North America Cancer Profiling Growth Rate (2017-2018)
Figure North America Cancer Profiling Revenue and Growth Rate (2017-2018)
Figure North America Cancer Profiling by Countries (2017-2018)
Figure North America Cancer Profiling Revenue (Million USD) by Countries (2017-2018)
Figure United States Cancer Profiling Growth Rate (2017-2018)
Figure United States Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Cancer Profiling Growth Rate (2017-2018)
Figure Canada Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Cancer Profiling Growth Rate (2017-2018)
Figure Mexico Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Cancer Profiling Growth Rate (2017-2018)
Figure Europe Cancer Profiling Revenue and Growth Rate (2017-2018)
Figure Europe Cancer Profiling by Countries (2017-2018)
Figure Europe Cancer Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Germany Cancer Profiling Growth Rate (2017-2018)
Figure Germany Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Cancer Profiling Growth Rate (2017-2018)
Figure France Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Cancer Profiling Growth Rate (2017-2018)
Figure UK Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Cancer Profiling Growth Rate (2017-2018)
Figure Russia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Cancer Profiling Growth Rate (2017-2018)
Figure Italy Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Cancer Profiling Growth Rate (2017-2018)
Figure Rest of Europe Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Profiling Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Profiling Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Profiling by Countries (2017-2018)
Figure Asia-Pacific Cancer Profiling Revenue (Million USD) by Countries (2017-2018)
Figure China Cancer Profiling Growth Rate (2017-2018)
Figure China Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Cancer Profiling Growth Rate (2017-2018)
Figure Japan Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Cancer Profiling Growth Rate (2017-2018)
Figure Korea Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Cancer Profiling Growth Rate (2017-2018)
Figure India Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Cancer Profiling Growth Rate (2017-2018)
Figure Southeast Asia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Profiling Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Cancer Profiling Growth Rate (2017-2018)
Figure South America Cancer Profiling Revenue and Growth Rate (2017-2018)
Figure South America Cancer Profiling by Countries (2017-2018)
Figure South America Cancer Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Cancer Profiling Growth Rate (2017-2018)
Figure Brazil Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Cancer Profiling Growth Rate (2017-2018)
Figure Argentina Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Cancer Profiling Growth Rate (2017-2018)
Figure Columbia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Cancer Profiling Growth Rate (2017-2018)
Figure Rest of South America Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Profiling Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Profiling Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Profiling by Countries (2017-2018)
Figure Middle East and Africa Cancer Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Cancer Profiling Growth Rate (2017-2018)
Figure Saudi Arabia Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Profiling Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Cancer Profiling Growth Rate (2017-2018)
Figure Egypt Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Cancer Profiling Growth Rate (2017-2018)
Figure Nigeria Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Cancer Profiling Growth Rate (2017-2018)
Figure South Africa Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Cancer Profiling Growth Rate (2017-2018)
Figure Turkey Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Profiling Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Table Qiagen N.V. Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table HTG Molecular Diagnostics, Inc Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Caris Life Sciences Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table NanostringTechologies Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ribomed Biotechnologies, Inc. Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina, Inc. Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Neogenomics Laboratories Inc., Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Genomic Health Inc Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Helomics Corporation Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Oxford Gene Technology Cancer Profiling Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Cancer Profiling Market Share by Manufacturer
Figure Global Cancer Profiling Revenue and Market Share by Manufacturer
Table Global Cancer Profiling Price by Region (2017-2017)
Figure Top 5 Cancer Profiling Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Cancer Profiling Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Profiling Market Forecast by Regions (2018-2025)
Figure North America Cancer Profiling Market Forecast (2018-2025)
Figure United States Cancer Profiling Market Forecast (2018-2025)
Figure Canada Cancer Profiling Market Forecast (2018-2025)
Figure Mexico Cancer Profiling Market Forecast (2018-2025)
Figure Europe Cancer Profiling Market Forecast (2018-2025)
Figure Germany Cancer Profiling Market Forecast (2018-2025)
Figure France Cancer Profiling Market Forecast (2018-2025)
Figure UK Cancer Profiling Market Forecast (2018-2025)
Figure Russia Cancer Profiling Market Forecast (2018-2025)
Figure Italy Cancer Profiling Market Forecast (2018-2025)
Figure Rest of Europe Cancer Profiling Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Profiling Market Forecast (2018-2025)
Figure China Cancer Profiling Market Forecast (2018-2025)
Figure Japan Cancer Profiling Market Forecast (2018-2025)
Figure Korea Cancer Profiling Market Forecast (2018-2025)
Figure India Cancer Profiling Market Forecast (2018-2025)
Figure Southeast Asia Cancer Profiling Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Profiling Market Forecast (2018-2025)
Figure South America Cancer Profiling Market Forecast (2018-2025)
Figure Brazil Cancer Profiling Market Forecast (2018-2025)
Figure Argentina Cancer Profiling Market Forecast (2018-2025)
Figure Columbia Cancer Profiling Market Forecast (2018-2025)
Figure Rest of South America Cancer Profiling Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Profiling Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Profiling Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Profiling Market Forecast (2018-2025)
Figure Egypt Cancer Profiling Market Forecast (2018-2025)
Figure Nigeria Cancer Profiling Market Forecast (2018-2025)
Figure South Africa Cancer Profiling Market Forecast (2018-2025)
Figure Turkey Cancer Profiling Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Profiling Market Forecast (2018-2025)
Figure Global Cancer Profiling Forecast by Technology (2018-2025)
Figure Global Cancer Profiling Market Share Forecast by Technology (2018-2025)
Figure Global Cancer Profiling Forecast by Technology (2018-2025)
Figure Global Cancer Profiling Forecast by Technique (2018-2025)
Figure Global Cancer Profiling Market Share Forecast by Technique (2018-2025)
Figure Global Cancer Profiling Forecast by Technique (2018-2025)
Figure Global Cancer Profiling Forecast by Application (2018-2025)
Figure Global Cancer Profiling Market Share Forecast by Application (2018-2025)
Figure Global Cancer Profiling Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|